Abstract
The role of the liver in the plasma clearance of l-dopa in the rat was examined. Some published studies which ascribe an important role to the liver in l-dopa clearance are discussed and critically evaluated. Contrary evidence suggesting that the liver is not a significant site of l-dopa clearance in vivo ispresented. The plasma concentration of l-dopa during intravenous infusion of the drug was not significantly reduced after a single passage through the liver. All of the data discussed are consistent with the conclusion that the liver plays a minor role in l-dopa clearance in vivo.It is suggested that the small intestine is the major site of metabolism of orally administered l-dopa.
Similar content being viewed by others
References
J. Bergmark, A. Carlsson, A. Granerus, R. Jagenburg, T. Magnusson, and A. Svanborg. Decarboxylation of orally administeredl-dopa in the human digestive tract.Naunyn-Schmeideberg's Arch. Pharmacol. 272: 437–440 (1972).
C. B. Coutinho, H. E. Spiegel, S. A. Kaplan, M. Yu, R. P. Christian, J. J. Carbone, J. Symington, J. A. Cheripko, J. A. Lewis, M. Tonchen, and T. Crews. Kinetics of absorption and excretion of levodopa in dogs.J. Pharm. Sci. 60: 1014–1019 (1971).
L. Rivera-Calimlim, J. P. Morgan, C. A. Dujovne, J. Bianchine, and L. Lasagna.l-3,4-Dihydroxyphenylalanine metabolism by the gutin vitro.Biochem. Pharmacol. 20: 3051–3057 (1971).
T. L. Sourkes. Dopa decarboxylase: Substrates, co-enzymes and inhibitors.Pharmacol. Rev. 18: 53–60 (1966).
Y. Osumi, I. Wada, and M. Fujiwara. The conversion of exogenously administeredl-dopa to dopamine in the stomach and liver of rats.Japan J. Pharmacol. 22: 723–726 (1972).
G. Tyce. Metabolism of 3,4-dihydroxyphenylalanine by isolated perfused rat liver.Biochem. Pharmacol. 20: 3447–3462 (1971).
G. M. Tyce and C. A. Owen. Effect ofl-aromatic amino acid decarboxylase inhibition on metabolism of dihydroxyphenylalanine by isolated perfused rat liver.Biochem. Pharmacol. 21: 2977–2989 (1972).
M. Rowland. Application of clearance concepts to some literature data on drug metabolism in the isolated perfused liver preparation andin vivo.Europ. J. Pharmacol. 17: 352–356 (1972).
M. Rowland, L. Z. Benet, and G. G. Graham. Clearance concepts in pharmacokinetics.J. Pharmacokin. Biopharm. 1: 123–136 (1973).
E. V. Flock and C. A. Owen. Metabolism of thyroid hormones and some derivatives in isolated perfused rat liver.Am. J. Physiol. 209: 1039–1045 (1965).
E. L. Dobson and H. B. Jones. The behaviour of intravenous injected particulate material: Its rate of disappearance from the blood stream as a measure of liver blood flow.Acta Med. Scand. 144: 34, Suppl. 273 (1952).
H. E. Spiegel and A. E. Tonchen. Semiautomated method for measurement of dopa in plasma.Clin. Chem. 16: 763–765 (1970).
L. A. Sapirstein and G. E. Hanusek. Cerebral blood flow in the rat.Am. J. Physiol. 193: 272–274 (1958).
P. T. Mearrick. D. N. Wade, and J. L. Morris. The role of the small intestine in the metabolism ofl-dopa in the rat.Proc. Aust. Soc. Med. Res. 3: 170, abst. (1973).
D. N. Wade, P. T. Mearrick, and J. L. Morris. Active transport ofl-dopa in the intestine.Nature 242: 463–465 (1973).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mearrick, P.T., Graham, G.G. & Wade, D.N. The role of the liver in the clearance ofl-dopa from plasma. Journal of Pharmacokinetics and Biopharmaceutics 3, 13–23 (1975). https://doi.org/10.1007/BF01066592
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01066592